SQZ Biotechnologies Total Assets 2020-2022 | SQZ

SQZ Biotechnologies total assets from 2020 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
SQZ Biotechnologies Annual Total Assets
(Millions of US $)
2021 $226
2020 $231
2019 $152
SQZ Biotechnologies Quarterly Total Assets
(Millions of US $)
2022-06-30 $180
2022-03-31 $201
2021-12-31 $226
2021-09-30 $244
2021-06-30 $239
2021-03-31 $263
2020-12-31 $231
2020-09-30 $177
2020-06-30 $0
2020-03-31 $0
2019-12-31 $0
2019-09-30 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.068B $0.027B
SQZ Biotechnologies Company is a clinical-stage biotechnology company. It develops transformative cell therapies for patients with cancer, infectious diseases and other serious conditions. The company's prime product candidate consist SQZ-PBMC-HPV which is in clinical stage. SQZ Biotechnologies Company is based In Watertown, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $150.984B 9.16
GSK (GSK) United Kingdom $59.709B 7.17
Bio-Rad Laboratories (BIO.B) United States $12.433B 27.47
Biohaven Pharmaceutical Holding (BHVN) United States $10.873B 0.00
QIAGEN (QGEN) Netherlands $9.383B 15.71
Ginkgo Bioworks Holdings (DNA) United States $4.998B 0.00
Arcus Biosciences (RCUS) United States $1.819B 35.51
Myovant Sciences (MYOV) United Kingdom $1.614B 0.00
Emergent Biosolutions (EBS) United States $1.040B 6.03
ADC Therapeutics SA (ADCT) Switzerland $0.376B 0.00
Zymeworks (ZYME) Canada $0.305B 0.00
Enzo Biochem (ENZ) United States $0.105B 0.00
Gelesis Holdings (GLS) United States $0.081B 0.00
Ambrx Biopharma (AMAM) United States $0.041B 0.00